41 results on '"Park, Sang-Yoon"'
Search Results
2. Comparison of survival outcomes between olaparib and niraparib maintenance therapy in BRCA-mutated, newly diagnosed advanced ovarian cancer
3. Impact of postoperative residual disease on survival in epithelial ovarian cancer with consideration of recent frontline treatment advances: A systematic review and meta-analysis
4. Impact of warm saline irrigation, hyperthermic intraperitoneal chemotherapy on postoperative pain in primary ovarian cancer from the KOV-HIPEC-01 randomized trial
5. Cost-effectiveness of hyperthermic intraperitoneal chemotherapy following interval cytoreductive surgery for stage III-IV ovarian cancer from a randomized controlled phase III trial in Korea (KOV-HIPEC-01)
6. Real-world effectiveness of bevacizumab based on AURELIA in platinum-resistant recurrent ovarian cancer (REBECA): A Korean Gynecologic Oncology Group study (KGOG 3041)
7. Involved-field radiation therapy for recurrent ovarian cancer: Results of a multi-institutional prospective phase II trial
8. BRCA1/2 mutations associated with progression-free survival in ovarian cancer patients in the AGO-OVAR 16 study
9. The clinical value of surgeons' efforts of preventing intraoperative tumor rupture in stage I clear cell carcinoma of the ovary: A Korean multicenter study
10. Hyperthermic intraperitoneal chemotherapy for epithelial ovarian cancer: A meta-analysis
11. Development and evaluation of the Korean version of the Gynecologic Cancer Lymphedema Questionnaire in gynecologic cancer survivors
12. Transabdominal cardiophrenic lymph node dissection (CPLND) via incised diaphragm replace conventional video-assisted thoracic surgery for cytoreductive surgery in advanced ovarian cancer
13. Clinical outcomes of BRCA1/2 pathogenic variants in ovarian cancer cluster region in patients with primary peritoneal, epithelial ovarian, and fallopian tube cancer
14. Extended cytoreduction of tumor at the porta hepatis by an interdisciplinary team approach in patients with epithelial ovarian cancer
15. Interaction between preoperative CA-125 level and survival benefit of neoadjuvant chemotherapy in advanced epithelial ovarian cancer
16. Sentinel lymph node biopsy in endometrial cancer: Meta-analysis of 26 studies
17. Predicting the risk of the distant recurrence of cervical cancer after concurrent chemoradiation: A validation study of the Korean Gynecologic Oncologic Group (KGOG)-1024 model
18. Incidence and outcomes of malignant ovarian germ cell tumors in Korea, 1999–2017
19. Natural history of persistent high-risk human papillomavirus infections in Korean women
20. Final primary analysis in the original cohort of KGOG3046/TRU-D: A phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage ovarian cancer (LBA 8)
21. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer
22. KGOG 3046/TRU-D: a phase II study of durvalumab and tremelimumab with front-line neoadjuvant chemotherapy in patients with advanced-stage epithelial ovarian cancer
23. Standardization of cytoreductive surgery is a precondition for clinical trials of ovarian cancer including cytoreductive surgery and/or neoadjuvant chemotherapy
24. Identification of a patient group at low risk for parametrial invasion in early-stage cervical cancer
25. Ovarian clear cell carcinoma: High risk of venous thromboembolism
26. Pathologic diagnosis and resection of suspicious thoracic metastases in patients with cervical cancer through thoracotomy or video-assisted thoracic surgery
27. Surgical results of hepatic metastatectomy in patients with primary epithelial ovarian carcinoma
28. E-NOTES: Promising minimal surgical approach for gynecologic disease
29. Total colectomy as part of primary cytoreductive surgery in advanced Müllerian cancer
30. The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer
31. Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancer
32. The association of pre-conization high-risk HPV load and the persistence of HPV infection and persistence/recurrence of cervical intraepithelial neoplasia after conization
33. Primary Ewing's sarcoma-primitive neuroectodermal tumor of the uterus: A case report and literature review
34. Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma
35. The benefits of low anterior en bloc resection as part of cytoreductive surgery for advanced primary and recurrent epithelial ovarian cancer patients outweigh morbidity concerns
36. Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: From diagnosis to prognosis
37. Pretreatment laparoscopic surgical staging in locally advanced cervical cancer: Preliminary results in Korea
38. Relationship between Squamous Cell Carcinoma Antigen Levels and Tumor Volumes in Patients with Cervical Carcinomas Undergoing Neoadjuvant Chemotherapy
39. β-Core Fragment (β-Core/UGF/UGP), a Tumor Marker: A 7-Year Report
40. Risk factors predicting residual disease in subsequent hysterectomy following conization for cervical intraepithelial neoplasia (CIN) III and microinvasive cervical cancer
41. Pretreatment laparoscopic surgical staging in locally advanced cervical cancer: preliminary results in Korea.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.